GSK - NYSE - 3/15/2010 8:00 PM
| Current | Overall Rank | Sector Rank | Industry Rank |
|---|---|---|---|
| 9.20% | 391 / 2557 | 44 / 244 | 6 / 13 |
| Healthcare | Drug Manufacturers - Major |
| Period | Earning Yield |
|---|---|
| Dec/01 | 2.91% |
| Dec/02 | 5.63% |
| Mar/03 | 6.34% |
| Jun/03 | 5.82% |
| Sep/03 | 6.11% |
| Dec/03 | 5.62% |
| Mar/04 | 6.68% |
| Jun/04 | 6.30% |
| Sep/04 | 6.04% |
| Dec/04 | 5.78% |
| Mar/05 | 6.16% |
| Jun/05 | 5.85% |
| Sep/05 | 5.67% |
| Dec/05 | 5.86% |
| Mar/06 | 5.91% |
| Jun/06 | 5.75% |
| Sep/06 | 6.35% |
| Dec/06 | 5.88% |
| Mar/07 | 5.85% |
| Jun/07 | 6.36% |
| Sep/07 | 6.33% |
| Dec/07 | 6.67% |
| Jun/08 | 7.39% |
| Sep/08 | 7.48% |
| Dec/08 | 9.26% |
| Mar/09 | 10.14% |
| Jun/09 | 8.77% |
| Sep/09 | 7.64% |
| Dec/09 | 8.21% |
| 3/15 | 9.20% |
RT @HometownStocks: Perspectives on Strategic M&A in Pharma by Pfizer Inc. Capital IQ Monthly Market Observations 03/10. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
CapitalIQ about 20 hours ago.
Perspectives on Strategic M&A in Pharma by Pfizer Inc. Capital IQ Monthly Market Observations 03/10. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about 3 days ago.
Pharma trend: looking at complementary or diversified businesses. keynote by Kristin Peck. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about 3 days ago.
Pharma trend: Huge growth in emerging markets like China. keynote by Kristin Peck. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about 3 days ago.
Pharma trend: Revenue declines. Return on R&D declines. Industry consolidation. keynote by Kristin Peck. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about 3 days ago.
Pharma trend: Generic’s are the winners when things go off the patent. keynote by Kristin Peck. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about 3 days ago.
Pharma trend: loss of exclusivity, $314B in products patent expire in next 5 yrs. keynote by Kristin Peck.$PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about 3 days ago.
Glaxo $GSK puts Dr Moncef Slaoui in charge of biologics in addition to his current R & D job.
mhuckman about 4 days ago.
The Next Big Opportunity for Big #Pharma Is BRIC http://is.gd/aevn5 $AZN $GSK
WriterChik about 5 days ago.
[$$] FDA Will Review Fosamax, Boniva for Safety (at The Wall Street Journal Online)
Mar 10 06:33 PM EST.
FDA to Review Bone Drugs After Studies Report Hip Breaks (at The Wall Street Journal Online)
Mar 10 05:55 PM EST.
Detailed backstory on the Glaxo $GSK perfume/cervical cancer spot on the Oscars. http://tinyurl.com/pmgskperf
mhuckman about 7 days ago.
Feb 22 11:47 AM EST.
GlaxoSmithKline's Human Papilloma Virus Vaccine to Compete with Merck's Gardasil
Oct 16 04:44 PM EDT.
Looking forward to participating in SXSWi panel "Data Is Money" with @apatzer, @womanwportfolio, Jesper Anderson, Allison Brady #datamoney
about 3 days ago. | Follow Us